A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/179, 358/23
A61K 31/00 (2006.01) A61K 33/24 (2006.01) A61K 38/45 (2006.01) A61N 5/00 (2006.01)
Patent
CA 1336409
The effectiveness of cytostatic and/or cytotoxic drugs and/or radiation in the killing of tumor and/or cancer cells is increased by the administration, along with said drugs and radiation, of an effective activat- ing or inhibiting amount of a compound or agent which activates or inhibits the chromatin-bound enzyme adeno- sine diphosphate ribosyl transferase (ADPRT) or the ad- ministration of an effective intracellular free Ca++- increasing amount of a compound which induces cellular or oxidative stress or which acts as an inhibitor or antagonist or calmodulin or Ca++-calmodulin binding. Suitable such compounds or agents include the pheno- thiazines, antihistamines, butyrophenones, cannabinoids and corticosteriods and particularly metoclopramide when employed in combination with cisplatin.
575624
Cassan Maclean
Oxi-Gene Inc.
LandOfFree
Tumor or cancer cell killing therapy and agents useful therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor or cancer cell killing therapy and agents useful therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor or cancer cell killing therapy and agents useful therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1292823